Early high-affinity neutralizing anti-viral IgG responses without further overall improvements of affinity.

Por Roost, H P, Bachmann, M F, Haag, A, Kalinke, U, Pliska, V, Hengartner, H, Zinkernagel, R M
Publicado em 1995

Low frequency of HLA-DRB1*11 in hepatitis C virus induced end stage liver disease

Por Tillmann, H, Chen, D, Trautwein, C, Kliem, V, Grundey, A, Berning-Haag, A, Boker, K, Kubicka, S, Pastucha, L, Stangel, W, Manns, M
Publicado em 2001

Intravenous immunoglobulins containing antibodies against ß-amyloid for the treatment of Alzheimer's disease

Por Dodel, R, Du, Y, Depboylu, C, Hampel, H, Frolich, L, Haag, A, Hemmeter, U, Paulsen, S, Teipel, S, Brettschneider, S, Spottke, A, Nolker, C, Moller, H, Wei, X, Farlow, M, Sommer, N, Oertel, W
Publicado em 2004

Partial Complementation of Sinorhizobium meliloti bacA Mutant Phenotypes by the Mycobacterium tuberculosis BacA Protein

Por Arnold, M. F. F., Haag, A. F., Capewell, S., Boshoff, H. I., James, E. K., McDonald, R., Mair, I., Mitchell, A. M., Kerscher, B., Mitchell, T. J., Mergaert, P., Barry, C. E., Scocchi, M., Zanda, M., Campopiano, D. J., Ferguson, G. P.
Publicado em 2013